Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease (BMC Cancer, (2020), 20, 1, (1210), 10.1186/s12885-020-07662-y)

by Collins, DC, Sundar, R, Constantinidou, A, Dolling, D, Yap, TA, Popat, S, O’Brien, ME, Banerji, U, de Bono, JS, Lopez, JS, Tunariu, N, Minchom, A
Published 2021

Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease

by Collins, DC, Sundar, R, Constantidinou, A, Dolling, D, Yap, TA, Popat, S, O’Brien, ME, Banerji, U, de Bono, JS, Lopez, JS, Tunariu, N, Minchom, A
Published 2021

Microstructure characterization of bone metastases from prostate cancer with diffusion MRI: Preliminary findings

by Bailey, C., Collins, D.J., Tunariu, N., Orton, M.R., Morgan, V.A., Feiweier, T., Hawkes, D.J., Leach, M.O., Alexander, D.C., Panagiotaki, E.
Published 2022

Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer

by Basu, B, Krebs, MG, Sundar, R, Wilson, RH, Spicer, J, Jones, R, Brada, M, Talbot, DC, Steele, N, Garces, AH Ingles, Brugger, W, Harrington, EA, Evans, J, Hall, E, Tovey, H, de Oliveira, FM, Carreira, S, Swales, K, Ruddle, R, Raynaud, FI, Purchase, B, Dawes, JC, Parmar, M, Turner, AJ, Tunariu, N, Banerjee, S, de Bono, JS, Banerji, U
Published 2021